Business / Finance

RSS

Merck expects 2011 non-GAAP EPS to be in the range of $3.64 to $3.76

Following the Merck and Johnson & Johnson settlement announcement today, Merck said that it continues to expect 2011 non-GAAP earnings per share to be in the range of $3.64 to $3.76, excluding certain items.

16 Apr 2011

Johnson & Johnson provides further details regarding distribution rights for REMICADE, SIMPONI

Johnson & Johnson provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE (infliximab) and SIMPONI (golimumab) in markets outside the United States. The amended agreement announced today in a separate news release from both companies concludes a pending arbitration, which had been filed by Johnson & Johnson in May 2009.

16 Apr 2011

Merck begins tender offer for all Inspire shares

Merck, known as MSD outside the United States and Canada, today announced the commencement of the tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc. for $5.00 per share in cash without interest and less any applicable withholding taxes.

15 Apr 2011

RXi prices underwritten public offering of 11,950,000 shares of common stock

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using immunotherapy and RNA-targeted technologies, today announced that it has priced an underwritten public offering of 11,950,000 units at a price to the public of $1.00 per unit for gross proceeds of approximately $12 million.

15 Apr 2011

Alliance HealthCare Services acquires 24/7 Radiology

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced the acquisition of 24/7 Radiology, a professional radiology services company, which provides both preliminary and final professional radiology interpretation services for MRI, CT, ultrasound, X-Ray and other imaging modalities in 18 states.

15 Apr 2011

RXi Pharmaceuticals acquires Apthera

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced the completion of its previously announced acquisition of Apthera, Inc.

15 Apr 2011

SXC enters definitive agreement to acquire MedMetrics

SXC Health Solutions Corp., announced today it has entered into a definitive agreement to acquire substantially all of the assets of MedMetrics Health Partners, Inc., the full-service PBM subsidiary of Public Sector Partners, Inc. which is affiliated with a major medical school.

12 Apr 2011

Shrink Nanotechnologies to acquire Nanopoint

Shrink Nanotechnologies, Inc., an innovative high technology company, announced today that it has executed a binding letter of intent to acquire 100% of Hawaii-based Nanopoint Inc., a biomedical instrumentation and microfluidics company with global distribution for its award-winning suites of life sciences products.

12 Apr 2011

Nano Terra announces acquisition of Surface Logix

Nano Terra, Inc., a leading surface engineering and nanotechnology co-development company, today announced it is acquiring Surface Logix, Inc., a drug development company founded by renowned Harvard scientist Professor George Whitesides. Surface Logix has made significant breakthroughs in enhancing the molecular functionality of pharmaceuticals and advancing several drug candidates.

12 Apr 2011

Biomet net sales increase 1% to $678 million for third fiscal quarter 2011

Biomet, Inc. announced today financial results for its third fiscal quarter ended February 28, 2011.

12 Apr 2011

VitaminSpice receives revised PO from West & Associates for $6.94 million

VitaminSpice has received a revised purchase order that increases the previous $5 million, March 9, 2011 Purchase Order, to $6.94 million. VitaminSpice received the revised PO from West and Associates, Las Vegas.

12 Apr 2011

Novelos Therapeutics acquires Cellectar

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has completed its acquisition of Cellectar, Inc., a Wisconsin-based drug development company, in a stock-for-stock transaction.

12 Apr 2011

Lantheus begins exchange offer for eligible holders

NLantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that on April 8, 2011 it commenced an exchange offer for eligible holders to exchange any and all of the company's outstanding unregistered 9.75% Senior Notes due 2017.

11 Apr 2011

Endo Pharmaceuticals to acquire American Medical Systems

Endo Pharmaceuticals and American Medical Systems today that they have entered into a definitive agreement under which Endo will acquire AMS, a leading provider of world-class devices and therapies for male and female pelvic health, for $30 per share, or $2.9 billion in cash, which includes the assumption and repayment of $312 million of AMS debt.

11 Apr 2011

Sanofi-aventis acquires Genzyme

Sanofi-aventis announced today that it has completed its acquisition of Genzyme Corporation, which is now a wholly-owned subsidiary of sanofi-aventis.

11 Apr 2011

QAD and Strategic Information Group to host Southern California Life Sciences Executive Forum

QAD Inc., a leading provider of enterprise business software and services for global manufacturing companies and its partner, Strategic Information Group (Strategic), announced today they will host the Southern California Life Sciences Executive Forum on April 12, 2011.

8 Apr 2011

McKinley Infocapital to distribute Biofield Breast Diagnostic System in Korea

Biofield Corp. announced today that its 51% owned subsidiary, Sky Unicorn Holdings Ltd., has engaged McKinley Infocapital as its exclusive distributor in Korea for its flagship product, the Biofield Breast Diagnostic System (BDS). McKinley Infocapital, an international business consulting and investment management firm, has formed MacKay Life Sciences Korea to market and promote the BDS in Korea.

8 Apr 2011

Kaydon completes HAHN-Gasfedern acquisition

Kaydon Corporation today announced that it has completed the acquisition of all of the outstanding shares of HAHN-Gasfedern GmbH and related real estate and intangible property ("Hahn") from Ulrich Hahn e.K. pursuant to the definitive agreement announced on February 25, 2011.

8 Apr 2011

BSD Medical second quarter net loss decreases 19% to $1,554,000

BSD Medical Corporation, a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its second fiscal quarter ended February 28, 2011.

8 Apr 2011

Unity receives first order for new BD Italian Tablet press

Unity Management Group, Inc. is a Health Resource Company specializing in Physician, and Hospital Practice Management, Business Services, Billing Software and Technologies, along with Pharmacy Instrumentation, Calibration, Data Acquisition, and Equipment Distribution.

8 Apr 2011